Effect of narrative nursing combined with cognitive behavioral rehabilitation on cognitive function and anxiety in patients with Alzheimer's disease

ISRCTN ISRCTN10742199
DOI https://doi.org/10.1186/ISRCTN10742199
Submission date
21/03/2025
Registration date
27/03/2025
Last edited
26/03/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that significantly impacts cognitive function and quality of life. AD patients experience anxiety, which can exacerbate cognitive decline through stress-related mechanisms. This study aims to investigate the effect of narrative nursing combined with cognitive behavioral rehabilitation on cognitive function and anxiety in patients with AD.

Who can participate?
Patients with AD who meet the diagnostic criteria of AD in the 2018 Chinese guidelines for the diagnosis and treatment of dementia and cognitive impairment (II) attending the participating centre.

What does the study involve?
Narrative nursing combined with cognitive behavioral rehabilitation on cognitive function and anxiety in patients with AD. Cognitive behavioral rehabilitation includes: memory training, language communication skills training, computing ability training, and daily life ability training. The implementation of cognitive training is generally recommended to be 5-6 times a week, each time for 1 hour, lasting for 6 months, emphasizing the patient as the main body, and the time and intensity follow the principle of individualization. Cognitive behavioral rehabilitation training is designed and implemented by occupational therapists in hospitals.

What are the possible benefits and risks of participating?
Narrative nursing combined with cognitive behavioral rehabilitation may effectively increase cognitive function, reduce anxiety, and improve the ADL and QOL of patients with AD.

There are no possible risks in this study.

Where is the study run from?
Tianjin Medical University General Hospital, China

When is the study starting and how long is it expected to run for?
January 2020 to December 2022

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dai Li, lidai_2024@126.com

Contact information

Dr Dai Li
Public, Scientific, Principal Investigator

Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District
Tianjin
300052
China

ORCiD logoORCID ID 0009-0006-3287-5153
Phone +8602260363844
Email lidai_2024@126.com

Study information

Study designSingle-center randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet No participant information sheet available
Scientific titleEffect of narrative nursing combined with cognitive behavioral rehabilitation on cognitive function and anxiety in patients with Alzheimer's disease
Study hypothesisNarrative nursing combined with cognitive behavioral rehabilitation may effectively increase cognitive function, reduce anxiety and improve the ADL and QoL of patients with Alzheimer’s disease
Ethics approval(s)

Approved 25/04/2024, Ethics Committee of Tianjin Medical University General Hospital (No. 154, Anshan Road, Heping District, Tianjin, 300052, China; +86 022-60361044; zyyjgb_ll3@163.com), ref: IRB2024-YX-150-01

ConditionNursing care for patients with Alzheimer's disease
InterventionPatients with AD were selected using a random sampling method and divided equally into the observation group and the control group using a random number table. Patients in the control group received conventional nursing care. Patients in the observation group received narrative nursing combined with cognitive behavioral rehabilitation in addition to conventional nursing care.

Cognitive behavioral rehabilitation includes: memory training, language communication skills training, computing ability training, and daily life ability training. The implementation of cognitive training is generally recommended to be 5-6 times a week, each time for 1 hour, lasting for 6 months, emphasizing the patient as the main body, and the time and intensity follow the principle of individualization. Cognitive behavioral rehabilitation training is designed and implemented by occupational therapists in hospitals.
Intervention typeBehavioural
Primary outcome measureThe following primary outcome measures are assessed at baseline and 6 months:
1. Cognitive functions measured using Chinese versions of the MMSE and Montreal Cognitive Assessment (MoCA)
2. Anxiety measured using the Generalised Anxiety Disorder-7 (GAD-7) scale
3. Activities of Daily Living (ADLs) and quality of life (QoL) measured using the Alzheimer’s Disease Cooperative Study (ADCS)-ADL and Quality of Life in Alzheimer’s Disease (QoL-AD) scales
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date06/01/2020
Overall study end date31/12/2022

Eligibility

Participant type(s)Patient
Age groupMixed
SexBoth
Target number of participants172
Total final enrolment172
Participant inclusion criteria1. Meets the diagnostic criteria of AD in the 2018 Chinese guidelines for the diagnosis and treatment of dementia and cognitive impairment (II): Guidelines for the diagnosis and treatment of Alzheimer’s disease
2. Basic language ability for simple communication
3. Meets the requirements of medical ethics in our hospital, and their family members signed the informed consent form
Participant exclusion criteria1. Severe psychiatric disorders that would prevent participation in cognitive behavioral therapy
2. Acute or unstable cardiovascular conditions requiring intensive medical management
3. Severe cognitive impairment (Mini-Mental State Examination [MMSE] score ≤10) that would preclude meaningful participation in the intervention
Recruitment start date10/01/2020
Recruitment end date08/11/2020

Locations

Countries of recruitment

  • China

Study participating centre

Tianjin Medical University General Hospital
Tianjin
300052
China

Sponsor information

Tianjin Medical University General Hospital
Hospital/treatment centre

No. 154, Anshan Road, Heping District
Tianjin
300052
China

Phone +86 022 60363029
Email zyyjgb_zxd@163.com
Website https://www.tjmugh.com.cn/
ROR logo "ROR" https://ror.org/003sav965

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date31/12/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Dai Li, lidai_2024@126.com.

Editorial Notes

21/03/2025: Study's existence confirmed by the Ethics Committee of Tianjin Medical University General Hospital. The previous ethics approval has expired, and the new ethics approval date, effective from 25/04/2024, represents the approval now in effect.